Effects of photobleaching on selected advanced glycation end products in the human lens
© Holm et al.; licensee BioMed Central. 2015
Received: 30 December 2014
Accepted: 6 January 2015
Published: 16 January 2015
Cataract is the leading cause of blindness, especially in the developing world. To ease access to treatment, we have proposed that cataract could be treated non-invasively by photobleaching of the chemically modified proteins responsible for cataract formation. The present study was aimed at examining the optical and biochemical effects of the proposed treatment.
Human donor lenses were photobleaced using a 445 nm cw laser. Lens optical quality was assessed before and after photobleaching by light transmission and scattering. The concentration of the advanced glycation end products (AGEs) pentosidine, argpyrimidine, carboxymethyllysine, hydroimidazolone was measured.
Transmission increased and AGE-related fluorescence decreased significantly after photobleaching but no changes were observed in the concentration of the measured AGEs.
We found a significant effect of the photobleaching treatment on lens optical parameters but we could not associate the optical findings to a change in the concentration of the AGEs we measured. This finding suggests that other AGEs were responsible for the observed photobleaching of the human lens after laser treatment. The biochemical nature of the photochemical reactions associated with photobleaching remains to be elucidated.
In spite of an effective and relatively safe treatment, cataract remains the leading cause of blindness worldwide accounting for nearly 20 million cases . The majority of blind from cataract live in the developing nations that have poor coverage of ophthalmic care and inadequate access to cataract surgery . At present, cataract development cannot be prevented so the only way to combat blindness from cataract is by making cataract treatment more easily accessible. In the Western world, blindness from cataract is rare  but cataract remains an important cause for impaired visual function . In US, cataract extraction and IOL implantation is the most frequently performed procedure and the single largest item in the Medicare budget. In the Western world the need for cataract treatment is estimated to double within the next two decades  due to increased number of aged individuals in combination with a trend towards patients demanding treatment at an earlier stage in the disease process .
During aging and cataract formation the optical quality of the lens deteriorates because of increased scattering and absorption of incident light. Lens transparency is intimately related to the three-dimensional arrangement and optical interaction of the intrinsic lens proteins [7,8]. Cataract is a protein conformational disorder  whereby a number of posttranslational protein modifications induce a conformational change in the intrinsic lens proteins and/or crosslinking of lens proteins leading to a disorder in the arrangement of proteins. Furthermore, some of the protein modifications are chromophores that directly absorb light. The end result is decreased transmission of light to the retina and hence an impaired vision.
The posttranslational protein modifications involved in lens ageing have not been fully elucidated yet but they include deamidation , non-enzymatic cleavage , truncation  and racemization  and non-enzymatic glycation leading to the formation of advanced glycation end products . Advanced glycation products include chromophores and fluorophores, some of which are formed as protein crosslinking adducts. Numerous advanced glycation products have been detected in the human lens and their levels have been found to increase with age and increased further in cataractous lenses . In theory, manipulating some of the protein changes causing optical disturbance in cataract could provide an interesting basis for a non-surgical treatment of cataract. It has been shown by us [15,16] and others  that some of the age-related optical changes in the human lens can be reversed by non-invasive irradiation with short-wavelength or infrared laser irradiation. The aim of the present study was to examine if the optical changes observed in photobleached human lenses are caused by a change in the concentration of advanced glycation end products.
Intact human lenses were obtained from the Cornea Bank, Amsterdam (Euro Tissue Bank, Beverwijk, The Netherlands). Lenses were shipped and stored in Castor Oil (Sigma Aldrich, Brøndby, Denmark) as previously described . Lenses maintained optical clarity for several weeks in castor oil. The study adhered to the tenets of the Helsinki Declaration. The study was approved by the Regional Ethical Committee of the Capitol Region of Denmark (H-3-2011-035).
Lenses were placed in 5 mm path length quartz cuvettes filled with castor oil for optical analyses (transmission and scatter). One lens from a pair was kept as control and the other was photobleached with a 445 nm cw laser. Optical performance of the lens was measured before and after photobleaching.
White light transmission spectra were recorded as described previously . In short, a fibre-coupled broad-band white light source (DT-Mini-2-GS, Micropack, Ocean Optics, the Netherlands) was placed close to the anterior lens surface and transmitted light was collected close to the posterior lens surface by an integrating sphere (FOIS-1, Ocean Optics, the Netherlands) that was coupled to a spectrometer using an optical fibre (USB4000, Ocean Optics, The Netherlands). Transmission was measured through the central 2 mm of the lens in an anterior-posterior direction. Transmission was calculated as the ratio between transmitted and incident light after correction for background light levels.
Forward scattered light was measured as the angular distribution of a 661 nm laser (Coherent Cube, 661 nm, 100 mW, diode cw laser, spotsize 1 mm, divergence 1 mrad, Coherent Inc., Santa Clara, CA, USA). The laser light was aimed at the center of the lens in anterior-posterior sagittal direction. The intensity of the transmitted laser light was measured at different angles in 0.1 degree steps using a fibre coupled spectrometer (USB4000, Ocean Optics, The Netherlands). Scattering was evaluated as the angular intensity profile of the forward scattered light.
Lenses were photobleached in a 4x10 mm area covering the central part of the lens using a 445 nm laser (500 mW, RGBLase LLC, Fremont, CA, USA). An irradiation dose of 1.5 kJ/cm2 was used.
Lens sample preparation and measurement of advanced glycation end products
A cylindrical sample was taken from the central part of the lens in an anterior-posterior direction using a corkborer with an internal diameter of 3.5 mm. The lens samples were placed in 500 μl lysis buffer (150 mM NaCl, 50 mM Tris–HCl (pH = 7.4), protease inhibitor (Roche 04 693 124 001) and phosphatase inhibitor (Roche 04 906 837 001)). The lenses were mechanically homogenized with an Ultra-Turrax T8 (IKA Labortechnik) and left to lyse for 30 minutes on ice. Samples were lyophilized over night. After lyophilization the lens samples were kept at −80° C until they were analyzed for the concentration of advanced glycation end products.
Measurement of pentosidine and argpyrimidine
Lyophilised lens samples (5 mg/ml) were hydrolyzed using 6 N HCl, dried and reconstituted in 250 μl of water and filtered through 0.45 μm centrifugal filters. Pentosidine and argpyrimidine were measured by reversed-phase HPLC using a C18 column as previously described . The amino acid content of the acid hydrolysates was estimated by the ninhydrin assay . Standard curves for argpyrimidine and pentosidine were generated using respective synthetic standards run under the same conditions . The data were expressed as picomoles of pentosidine or argpyrimidine per μM amino acid.
Measurement of AGE fluorescence
Lyophilised lens samples (5 mg/ml) were suspended in 50 mM sodium phosphate buffer pH 7.4 and sonicated for 5 min with cooling. A power setting of 4 (approximately 40 W) and a 30% duty cycle were used with Branson Digital Sonifier (model S-450D, Branson Ultrasonics Co., Danbury, CT). Sonicated samples were centrifuged at 21,000 g for 30 min at 4°C. Protein was estimated in the supernatant using the BCA method. Fluorescence was measured in a Horiba Jobin Yvon Fluromax-4 Spectrofluorometer at excitation/emission wavelengths of 335/385 nm (pentosidine-like) and 370/440 nm (argpyrimidine-like) and expressed as arbitrary units.
Direct ELISA for CML and HI
Microplates were coated with 4 μg protein/well and direct ELISA was performed as previously described .
Transmission before and after photobleaching
White light transmission 450–650 nm
Blue light transmission (450–490 nm)
Paired t-test, white light transmission
Paired t-test, blue light transmission
0.70 ± 0.11 (0.48-0.84)
0.45 ± 0.15 (0.19-0.67)
Treated lens, before treatment
0.71 ± 0.09 (0.57-0.85)
0.45 ± 0.14 (0.22-0.67)
Treated lens, after treatment
0.76 ± 0.08 (0.64-0.89)
0.54 ± 0.13 (0.33-0.75)
Advanced glycation end products
Concentration of advanced glycation end products in control lenses and treated lenses
Pentosidine** (n = 10)
CML*(n = 8)
HI* (n = 8)
Argpyrimidine** (n = 8)
Signed rank sum test (p-value)
Cataract is an important health care problem. We have proposed to treat cataracts non-invasively by photobleaching the lens. The aim of the present study was to examine the effect of the photobleaching on the optical properties of the lens and to characterize changes in one set of posttranslational protein modifications responsible for cataract formation, advanced glycation end products. We found that the photobleaching procedure resulted in increased transmission of visible light and decreased lens autofluorescence indicating that the intrinsic lens chromophores and fluorophores were altered by the procedure. We did not find an effect on the scattering properties, probably because all treated lenses showed very little scattering prior to treatment and hence no improvement could be expected.
The visual disturbance experienced by patients with cataract is related to absorption and scattering of visible light. We found that transmission of light increased after treatment with the greatest increase in the blue part of the visible spectrum. This shows that blue-light absorbing chromophores were bleached by the photobleaching procedure. Absorption of blue light is a dominant feature of lens aging . Thus, the photobleaching procedure may have the potential to improve visual function in elderly patients with strongly absorbent lenses but the exact effects on visual function can only be evaluated by clinical testing. We were, however, not able to determine which chromophores were photobleached by the procedure in the present study. The ageing human lens contains a wide range of chromophores. The tryptophan metabolites, such as the kynurenines and xanthurenic acid, all absorb light in UVA-range . Most advanced glycation end products, such as vesperlysine , K2P  and OP-lysine  also absorb light in the UVA range. To the best of our knowledge, no chromophores absorbing with a peak around 440–450 nm has yet been described. Thus, the chromophores responsible for the effect observed in the present study remain to be discovered. The nature of the photochemical reactions involved in the photobleaching also remains to be further explored.
Irradiation of lenses with short wavelength light is usually thought of as cataractogenic. Irradiation with ultraviolet radiation, especially UVB, has been shown to lead to cataract formation in several animal species [28-30]. However, irradiation with longer wavelength UVA at 370 nm did not result in any observable damage to porcine lenses whereas the threshold for cataract formation was very low when shorter wavelengths of UV, i.e. 280–290 nm, was used . In the present study we used irradiation at 445 nm and did not find any observable harmful effects. Due to difficulties preserving human lenses for a prolonged time period in the laboratory and because lens samples were taken immediately after the photobleaching procedure for analysis of advanced glycation end products, the observations on potential harmful effects are limited to the immediate post-treatment period.
In conclusion, we found that transmission of visible light increased significantly after photobleaching in human lenses and that the AGE-like fluorescence also decreased after photobleaching, but these optical changes were not accompanied by a decrease in the concentration of the measured advanced glycation end products. However, we like to point out that we have measured only a few advanced glycation products, of which two (carboxymethyllysine and hydroimidazolone) are non-chromophoric and the decreased transmission in AGE-like fluorescence would have had to be caused by other AGEs than those we measured directly. Thus, the products we measured should be treated only as markers for advanced glycation end products. There could be many more advanced glycation products that could be affected by our photobleaching treatment; further studies are needed to verify this possibility. Thus, the chromophores involved in photobleaching remains to be elucidated.
The study was presented in part at the ISER 2012 Conference in Berlin. The study received financial support from the Danish Medical Research Council (Frie Forskningsråd: Sundhed og Sygdom) and Research to Prevent Blindness, NY and Ohio Lions Eye Research Foundation (RHN).
The study received grant support from the Danish Medical Research Council (Frie Forskningsråd: Sundhed og Sygdom) and Research to Prevent Blindness, NY and Ohio Lions Eye Research Foundation.
- Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–51.PubMed CentralPubMedGoogle Scholar
- Foster A. Who will operate on Africa’s 3 million curably blind people? Lancet. 1991;337:1267–9.PubMedView ArticleGoogle Scholar
- Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209–13.PubMedView ArticleGoogle Scholar
- Buch H, Vinding T, Nielsen NV. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. Ophthalmology. 2001;108:2347–57.PubMedView ArticleGoogle Scholar
- Tuulonen A, Salminen H, Linna M, Perkola M. The need and total cost of Finnish eyecare services: a simulation model for 2005–2040. Acta Ophthalmol. 2009;87(8):820–9.PubMedView ArticleGoogle Scholar
- Kessel L, Haargaard B, Boberg-Ans G, Henning V. Time trends in indication for cataract surgery. J Clinic Experiment Ophthalmol. 2011;2:174.View ArticleGoogle Scholar
- Ponce A, Sorensen C, Takemoto L. Role of short-range protein interactions in lens opacifications. Mol Vis. 2006;12:879–84.PubMedGoogle Scholar
- Stradner A, Foffi G, Dorsaz N, Thurston G, Schurtenberger P. New insight into cataract formation: Enhanced stability through mutual attraction. Phys Rev Lett. 2007;99(19):198103.PubMedView ArticleGoogle Scholar
- Bloemendal H, de Jong W, Jaenicke R, Lubsen NH, Slingsby C, Tardieu A. Ageing and vision: structure, stability and function of lens crystallins. Prog Biophysics Mol Biol. 2004;86:407–85.View ArticleGoogle Scholar
- Hains PG, Truscott RJ. Age-dependent deamidation of lifelong proteins in the human lens. Invest Ophthalmol Vis Sci. 2010;51:3107–14.PubMed CentralPubMedView ArticleGoogle Scholar
- Su SP, Lyons B, Friedrich M, McArthur JD, Song X, Xavier D, et al. Molecular signatures of long-lived proteins: autolytic cleavage adjacent to serine residues. Aging Cell. 2012;11:1125–7.PubMedView ArticleGoogle Scholar
- Friedrich MG, Lam J, Truscott RJ. Degradation of an old human protein: age-dependent cleavage of gammaS-crystallin generates a peptide that binds to cell membranes. J Biol Chem. 2012;287:39012–20.PubMed CentralPubMedView ArticleGoogle Scholar
- Truscott RJ. Macromolecular deterioration as the ultimate constraint on human lifespan. Ageing Res Rev. 2011;10:397–403.PubMedView ArticleGoogle Scholar
- Nagaraj RH, Linetsky M, Stitt AW. The pathogenic role of Maillard reaction in the aging eye. Amino Acids. 2012;42:1205–20.PubMedView ArticleGoogle Scholar
- Kessel L, Kalinin S, Soroka V, Larsen M, Johansson LBA. Impact of UVR-A on whole human lenses, supernatants of buffered human lens homogenates, and purified argpyrimidine and 3-OH-kynurenine. Acta Ophthalmol Scand. 2005;83:221–7.PubMedView ArticleGoogle Scholar
- Kessel L, Eskildsen L, van der Poel M, Larsen M. Non-invasive bleaching of the human lens by femtosecond laser photolysis. PLoS One. 2010;5:e9711.PubMed CentralPubMedView ArticleGoogle Scholar
- Ortwerth BJ, Chemoganskiy V, Olesen PR. Studies on Singlet Oxygen Formation and UVA Light-mediated Photobleaching of the Yellow Chromophores in Human Lenses. Exp Eye Res. 2002;74:217–29.PubMedView ArticleGoogle Scholar
- Holm T, Brogger-Jensen MR, Johnson L, Kessel L. Glutathione Preservation during Storage of Rat Lenses in Optisol-GS and Castor Oil. PLoS One. 2013;8:e79620.PubMed CentralPubMedView ArticleGoogle Scholar
- Kessel L, Lundeman JH, Herbst K, Andersen TV, Larsen M. Age-related changes in the transmission properties of the human lens and their relevance to circadian entrainment. J Cataract Refract Surg. 2010;36:308–12.PubMedView ArticleGoogle Scholar
- Puttaiah S, Biswas A, Staniszewska M, Nagaraj RH. Methylglyoxal inhibits glycation-mediated loss in chaperone function and synthesis of pentosidine in alpha-crystallin. Exp Eye Res. 2007;84:914–21.PubMedView ArticleGoogle Scholar
- Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129–46.PubMedView ArticleGoogle Scholar
- Grandhee SK, Monnier VM. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem. 1991;266:11649–53.PubMedGoogle Scholar
- Nahomi RB, Oya-Ito T, Nagaraj RH. The combined effect of acetylation and glycation on the chaperone and anti-apoptotic functions of human alpha-crystallin. Biochim Biophys Acta. 1832;2013:195–203.Google Scholar
- Roberts JE, Wishart JF, Martinez L, Chignell CF. Photochemical studies on xanthurenic acid. Photochem Photobiol. 2000;72:467–71.PubMedView ArticleGoogle Scholar
- Tessier F, Obrenovich M, Monnier VM. Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis. J Biol Chem. 1999;274:20796–804.PubMedView ArticleGoogle Scholar
- Cheng R, Feng Q, Argirov OK, Ortwerth BJ. K2P–a novel cross-link from human lens protein. Ann N Y Acad Sci. 2005;1043:184–94.PubMed CentralPubMedView ArticleGoogle Scholar
- Argirov OK, Lin B, Ortwerth BJ. 2-ammonio-6-(3-oxidopyridinium-1-yl)hexanoate (OP-lysine) is a newly identified advanced glycation end product in cataractous and aged human lenses. J Biol Chem. 2004;279:6487–95.PubMedView ArticleGoogle Scholar
- Giblin FJ, Leverenz VR, Padgaonkar VA, Unakar NJ, Dang L, Lin LR, et al. UVA light in vivo reaches the nucleus of the guinea pig lens and produces deleterious, oxidative effects. Exp Eye Res. 2002;75:445–58.PubMedView ArticleGoogle Scholar
- Dillon J, Roy D, Spector A, Walker ML, Hibbard LB, Borkman RF. UV laser photodamage to whole lenses. Exp Eye Res. 1989;49:959–66.PubMedView ArticleGoogle Scholar
- Mody Jr VC, Kakar M, Elfving A, Soderberg PG, Lofgren S. Ultraviolet radiation-B-induced cataract in albino rats: maximum tolerable dose and ascorbate consumption. Acta Ophthalmol Scand. 2006;84:390–5.PubMedView ArticleGoogle Scholar
- Oriowo OM, Cullen AP, Chou BR, Sivak JG. Action spectrum and recovery for in vitro UV-induced cataract using whole lenses. Invest Ophthalmol Vis Sci. 2001;42:2596–602.PubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.